Peptidase (Digestive Enzyme Blend)

Evidence Level
Limited
2 Clinical Trials
4 Documented Benefits
2/5 Evidence Score

Peptidase supplements contain proteolytic enzymes — most commonly fungal proteases and prolyl endopeptidases derived from Aspergillus oryzae and Aspergillus niger — that hydrolyze dietary proteins into smaller peptides and free amino acids. They are marketed for general digestion, post-meal comfort, and accidental gluten or casein exposure in sensitive populations. The most studied enzymes in this class are AN-PEP (Aspergillus niger prolyl endopeptidase) and AoS28 enzymes from Aspergillus oryzae, which target proline-rich peptide regions of gliadin (gluten) and casein. These enzymes do not 'cure' celiac disease and cannot replace a gluten-free diet, but in vitro and small clinical work suggests they can degrade modest gluten quantities during digestion. Sparse direct supplement RCT evidence; mechanism is well characterized.

Studied Dose 5,000-50,000 HUT or SAPU per dose with meals; AN-PEP studies have used ~100,000-500,000 PPI units. Take with the first bites of a protein-containing meal. Not a substitute for gluten-free diet in celiac disease.
Active Compound Fungal proteases including Aspergillus niger prolyl endopeptidase (AN-PEP), Aspergillus oryzae prolyl endopeptidases (AoS28A, AoS28B), and dipeptidyl peptidase IV (DPP-IV); usually dosed in SAPU or HUT enzyme activity units.

Benefits

General Digestive Comfort

Supplemental peptidase enzymes can augment endogenous gastric and pancreatic protease activity at high-protein meals. This may help reduce post-meal bloating, heaviness, or discomfort in individuals whose digestive output may be lower or temporarily stressed.

Gluten Peptide Breakdown Support

Prolyl endopeptidases from Aspergillus species can hydrolyze proline-rich immunogenic peptides of gluten in vitro and in gastric simulation models. This activity is the rationale for marketing AN-PEP-based peptidase blends as accidental-exposure support for gluten-avoiders.

Casein and Dairy Peptide Digestion

DPP-IV and related proteases support breakdown of beta-casomorphin and similar exorphin peptides from dairy. Some users avoiding casein-sensitive symptoms report perceived benefit when peptidase is taken with occasional dairy exposure.

Plant Protein Digestibility

Peptidase blends can help break down plant proteins (peas, lentils, beans) that contain protease inhibitors and oligopeptides resistant to standard digestion. May support amino acid availability and reduce bloating after high plant-protein meals.

Mechanism of action

1

Endopeptidase Cleavage Activity

Fungal endopeptidases cleave internal peptide bonds in dietary proteins, producing shorter peptides accessible to brush-border peptidases. This complements endogenous pepsin and pancreatic protease activity, particularly during high-protein meals.

2

Prolyl Bond Hydrolysis (AN-PEP)

Aspergillus niger prolyl endopeptidase specifically cleaves peptide bonds C-terminal to proline residues — bonds that are resistant to human gastric and pancreatic proteases. This makes AN-PEP uniquely suited to degrading proline-rich gluten and casein peptides.

3

DPP-IV Exopeptidase Activity

Dipeptidyl peptidase IV cleaves dipeptides from the N-terminus of peptides containing proline or alanine in the penultimate position. This enzyme efficiently degrades exorphin-class peptides like beta-casomorphin-7 from casein and similar fragments from gluten.

4

Gastric pH Compatibility

Fungal proteases — unlike many bacterial enzymes — retain activity across a broad pH range (~2-7), allowing them to begin working in the acidic stomach and continue in the duodenum. This pH flexibility makes them practical oral supplements.

Clinical trials

1
Aspergillus oryzae Prolyl Endopeptidases for Gluten Digestion

Production and biochemical characterization of two major secreted prolyl endopeptidases (AoS28A, AoS28B) from Aspergillus oryzae, with in vitro evaluation of their ability to degrade proline-rich gluten peptides under simulated gastric conditions. (Eugster et al, Microbiology)

In vitro enzyme characterization with gluten peptide substrates.

Both AoS28A and AoS28B efficiently hydrolyzed proline-rich gliadin peptides under gastric pH conditions, with activity comparable to the previously characterized Aspergillus niger AN-PEP enzyme. Establishes broader enzyme platform for fungal-protease-based gluten degradation, the mechanistic foundation for peptidase supplements marketed for accidental gluten exposure.

2
Pharmacological Approaches in Celiac Disease — Review

Review of pharmacological strategies for managing celiac disease, including enzyme therapy approaches using prolyl endopeptidases to degrade gluten. (McCarville et al, Curr Opin Pharmacol)

Narrative review of mechanisms and trials.

The review surveys peptidase and enzyme-detoxification approaches in celiac disease, noting that prolyl endopeptidases like AN-PEP can degrade gluten in gastric simulation models and in small human trials. Authors caution that enzymes are not substitutes for the gluten-free diet and that clinical efficacy for symptom prevention remains modest in trials to date.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated; mild GI upset, gas, or loose stool may occur.
Rare allergic reactions in individuals sensitive to fungal mold products.
Should not be relied upon to prevent celiac reactions to intentional gluten exposure.
Excessive doses may cause stomach discomfort or transient diarrhea.
Some users report nausea if taken on an empty stomach; always take with food.

Important Drug interactions

Diabetes medications (DPP-IV inhibitors like sitagliptin) — theoretical pharmacologic overlap; discuss with prescriber
Pancreatic enzyme replacement (pancrelipase) — additive proteolytic activity; coordinate dosing with prescriber
Anticoagulants — high-dose enzyme products may marginally affect coagulation; discuss with prescriber
Antibiotics — enzymes generally do not affect antibiotic absorption but separate dosing if uncertain

Frequently asked questions about Peptidase (Digestive Enzyme Blend)

What is the recommended dosage of Peptidase (Digestive Enzyme Blend)?

The clinically studied dose for Peptidase (Digestive Enzyme Blend) is 5,000-50,000 HUT or SAPU per dose with meals; AN-PEP studies have used ~100,000-500,000 PPI units. Take with the first bites of a protein-containing meal. Not a substitute for gluten-free diet in celiac disease.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Peptidase (Digestive Enzyme Blend) used for?

Peptidase (Digestive Enzyme Blend) is studied for general digestive comfort, gluten peptide breakdown support, casein and dairy peptide digestion. Supplemental peptidase enzymes can augment endogenous gastric and pancreatic protease activity at high-protein meals.

Are there side effects from taking Peptidase (Digestive Enzyme Blend)?

Reported potential side effects may include: Generally well-tolerated; mild GI upset, gas, or loose stool may occur. Rare allergic reactions in individuals sensitive to fungal mold products. Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does Peptidase (Digestive Enzyme Blend) interact with medications?

Known drug interactions may include: Diabetes medications (DPP-IV inhibitors like sitagliptin) — theoretical pharmacologic overlap; discuss with prescriber Pancreatic enzyme replacement (pancrelipase) — additive proteolytic activity; coordinate dosing with prescriber Consult a pharmacist or healthcare provider if you take prescription medications.

Is Peptidase (Digestive Enzyme Blend) good for gut health?

Yes, Peptidase (Digestive Enzyme Blend) is researched for Gut Health support. Supplemental peptidase enzymes can augment endogenous gastric and pancreatic protease activity at high-protein meals. This may help reduce post-meal bloating, heaviness, or discomfort in individuals whose digestive output may be lower or temporarily stressed.

References(2 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Eugster PJ, Salamin K, Grouzmann E, Monod M. Production and characterization of two major Aspergillus oryzae secreted prolyl endopeptidases able to efficiently digest proline-rich peptides of gliadin. Microbiology (Reading). 2015;161(12):2277-88. doi: 10.1099/mic.0.000198.PubMedUsed to support: Characterization of Aspergillus oryzae prolyl endopeptidases (AoS28A, AoS28B) efficient at digesting proline-rich gliadin peptides under gastric pH — mechanistic foundation for peptidase supplements targeting gluten exposure
  2. McCarville JL, Caminero A, Verdu EF. Pharmacological approaches in celiac disease. Curr Opin Pharmacol. 2015;25:7-12. doi: 10.1016/j.coph.2015.09.002.PubMedUsed to support: Review of pharmacological strategies for celiac disease including enzyme therapy with prolyl endopeptidases — supports peptidase mechanism while noting limitations of enzyme-only approach for clinically significant gluten exposure